Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Accumulated Expenses: 2009-2025

Historic Accumulated Expenses for Argan (AGX) over the last 17 years, with Oct 2025 value amounting to $67.1 million.

  • Argan's Accumulated Expenses fell 14.35% to $67.1 million in Q4 2025 from the same period last year, while for Oct 2025 it was $67.1 million, marking a year-over-year decrease of 14.35%. This contributed to the annual value of $83.3 million for FY2025, which is 1.96% up from last year.
  • According to the latest figures from Q4 2025, Argan's Accumulated Expenses is $67.1 million, which was down 6.03% from $71.5 million recorded in Q3 2025.
  • In the past 5 years, Argan's Accumulated Expenses ranged from a high of $83.3 million in Q1 2025 and a low of $39.4 million during Q2 2022.
  • Over the past 3 years, Argan's median Accumulated Expenses value was $68.8 million (recorded in 2023), while the average stood at $68.3 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first decreased by 19.25% in 2022, then skyrocketed by 106.73% in 2023.
  • Argan's Accumulated Expenses (Quarterly) stood at $42.7 million in 2021, then dropped by 5.69% to $40.2 million in 2022, then soared by 106.73% to $83.2 million in 2023, then fell by 5.77% to $78.4 million in 2024, then declined by 14.35% to $67.1 million in 2025.
  • Its Accumulated Expenses was $67.1 million in Q4 2025, compared to $71.5 million in Q3 2025 and $69.9 million in Q2 2025.